Casein glycomacropeptide in the diet may reduce Escherichia coli attachment to the intestinal mucosa and increase the intestinal lactobacilli of early weaned piglets after an enterotoxigenic E. coli K88 challenge

British Journal of Nutrition

Volumn 109, Issue 6, 2013, Pages 1001-1012

  Gustavo Hermes, Rafael ^a   Molist, Francesc ^a   Francisco Pérez, José ^a   De Segura, Arantza Gómez ^a   Ywazaki, Mauro ^a   Davin, Roger ^a   Nofrarías, Miquel ^b   Korhonen, Timo K ^c   Virkola, Ritva ^c   Martín Orúe, Susana María ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CENTRE DE RECERCA EN SANITAT ANIMAL CRESA   (Spain)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Bovine glycomacropeptide; Intestinal health; Microbiota; Piglets

Indexed keywords

AMMONIA; CASEIN GLYCOMACROPEPTIDE; GLYCOPROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM CULTURE; COLON; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENTEROTOXIGENIC ESCHERICHIA COLI; ENTEROTOXIGENIC ESCHERICHIA COLI K88; EPITHELIUM; FLUORESCENCE IN SITU HYBRIDIZATION; ILEUM; IN VITRO STUDY; IN VIVO STUDY; INTESTINE MUCOSA; LACTOBACILLUS; NONHUMAN; PIGLET; WEANING;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL ADHESION; CASEINS; DIET; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FIMBRIAE PROTEINS; INTESTINAL MUCOSA; INTESTINES; LACTOBACILLUS; PEPTIDE FRAGMENTS; SUS SCROFA; WEANING;

EID: 84875045595     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512002978     Document Type: Article

References (62)

1. Fairbrother JM, Nadeau É & Gyles CL (2005) Escherichia coliin postweaning diarrhea in pigs: an update on bacterialtypes, pathogenesis, and prevention strategies. AnimHealth Res Rev 6, 17-39.
2. Korhonen TK, Parkkinen J, Hacker J, et al. (1986) Binding ofEscherichia coli S fimbriae to human kidney epithelium.Infect Immun 54, 322-327. (Pubitemid 17171439)
3. Grange PA, Mouricout MA, Levery SB, et al. (2002) Evaluationof receptor binding specificity of Escherichia coli K88(F4) fimbrial adhesin variants using porcine serum transferrinand glycosphingolipids as model receptors. InfectImmun 70, 2336-2343. (Pubitemid 34408373)
4. Jin LZ & Zhao X (2000) Intestinal receptors for adhesive fimbriaeof enterotoxigenic Escherichia coli (ETEC) K88 inswine-a review. Appl Microbiol Biotechnol 54, 311-318.
5. Nagy B & Fekete PZ (2005) Enterotoxigenic Escherichia coliin veterinary medicine. Int J Med Microbiol 295, 443-454. (Pubitemid 41225455)
6. Van den Broeck W, Cox E, Oudega B, et al. (2000) The F4fimbrial antigen of Escherichia coli and its receptors. VetMicrobiol 71, 223-244. (Pubitemid 30070061)
7. Coddens A, Valis E, Benktander J, et al. (2011) Erythrocyteand porcine intestinal glycosphingolipids recognized by F4fimbriae of enterotoxigenic Escherichia coli. PLoS ONE 6,e23309.
8. Schwertmann A, Shroten H, Hacker H, et al. (1999) S-fimbriaefrom Escherichia coli bind to soluble glycoproteinsfrom human milk. J Pediatr Gastroenterol Nutr 28, 257-263. (Pubitemid 29293646)
9. Shahriar F, Ngeleka M, Gordon JR, et al. (2006) Identificationby mass spectroscopy of F4ac-fimbrial-binding proteins inporcine milk and characterization of lactadherin as an inhibitorof F4ac-positive Escherichia coli attachment to intestinalvilli in vitro. Develop Comp Immunol 30, 723-734.
10. Naughton PJ, Mikkelsen LL & Jensen BB (2001) Effects ofnondigestible oligosaccharides on Salmonella enterica serovartyph imurium and non-pathogenic Escherichia coli in thepig small intestine in vitro. Appl Environ Microbiol 67,3391-3395. (Pubitemid 33641205)
11. Newburg DS, Ruiz-Palacios GM, Altaye M, et al. (2004)Innate protection conferred by fucosylated oligosaccharidesof human milk against diarrhea in breastfed infants. Glycobiol14, 253-263. (Pubitemid 38324941)
12. Swaisgood HE (1992) Chemistry of the caseins. In AdvancedDairy Chemistry, vol. 1, pp. 63-110 [PF Fox, editor]. London:Elsevier Applied Science.
13. Thomä-Worringer C, Sørensen J & López- Fandiño R (2006)Health effects and technological features of caseinomacropeptide.Int Dairy J 16, 1324-1333. (Pubitemid 44348878)
14. LaClair CE, Ney DM, MacLeod EL, et al. (2009) Purificationand use of glycomacropeptide for nutritional managementof phenylketonuria. J Food Sci 74, 199-206.
15. Nakano T, Ikawa N & Ozimek L (2007) Detection of sialylatedphosphorylated kappa-casein glycomacropeptide electrophoresedon polyacrylamide gels and cellulose acetatestrips by the thiobarbituric acid and malachite green dyereactions. J Agric Food Chem 55, 2714-2726. (Pubitemid 46623770)
16. Brody EP (2000) Biological activities of bovine glycomacropeptide.Br J Nutr 84, 39-46.
17. Lonnerdal B (2003) Nutritional and physiologic significanceof human milk proteins. Am J Clin Nutr 77, 1537-1543.
18. Krissansen GW (2007) Emerging health properties of wheyproteins and their clinical implications. J Am Coll Nutr 26,713-723.
19. Kawasaki Y, Isoda H, Tanimoto M, et al. (1992) Inhibition bylactoferrin and k-casein glycomacropeptide of binding ofcholera toxin to its receptor. Biosci Biotechnol Biochem 56,195-198.
20. Idota T, Kawakami H & Nakajima I (1994) Growth-promotingeffects of N-acetylneuraminic acid-containing substanceson bifidobacteria. Biosci Biotechnol Biochem 58, 1720-1722.
21. Bouhallab S, Favrot C & Maubois JL (1993) Growthpromotingactivity of tryptic digest of caseino macropeptidefor Lactococcus lactis subsplactis. Lait 73, 73-77.
22. Wong PYY, Nakamura S & Kitts DD (2006) Functional andbiological activities of casein glycomacropeptide as influencedby lipophilization with medium and long chain fattyacid. Food Chem 97, 310-317. (Pubitemid 41828320)
23. Newburg DS (1997) Do the binding properties of oligosaccharidesin milk protect human infants from gastrointestinalbacteria? J Nutr 127, 980-984.
24. Rhoades JR, Gibson GR, Formentin K, et al. (2005) Caseinoglycomacropeptideinhibits adhesion of pathogenic Escherichiacoli strains to human cells in culture. J Dairy Sci 88,3455-3459. (Pubitemid 41624071)
25. Malkoski M, Dashper SG, O'Brien-Simpson NM, et al. (2001)Kappacin, a novel antibacterial peptide from bovine milk.Antimicrob Agents Chemother 45, 2309-2315. (Pubitemid 32664472)
26. Hermes RG, Manzanilla EG, Mart?́n-Orúe SM, et al. (2011)Influence of dietary ingredients on in vitro inflammatoryresponse of intestinal porcine epithelial cells challenged byan enterotoxigenic Escherichia coli (K88). Comp ImmunolMicrobiol Infect Dis 34, 479-488.
27. Daddaoua A, Puerta V, Zarzuelo A, et al. (2005) Bovine glycomacropeptideis anti-inflammatory in rats with hapteninducedcolitis. J Nutr 135, 1164-1170. (Pubitemid 40638322)
28. Chabance B, Marteau P, Rambaud JC, et al. (1998) Caseinpeptide release and passage to the blood in humansduring digestion of milk or yogurt. Biochimie 80, 155-165. (Pubitemid 28185054)
29. Ledoux N, Mahé S, Dubarry M, et al. (1999) Intraluminalimmunoreactive caseinomacropeptide after milk proteiningestion in humans. Nahrung 43, 196-200. (Pubitemid 129570448)
30. Fosset S, Fromentin G, Gietzen DW, et al. (2002) Peptidefragments released from phe-caseinomacropeptide in vivoin the rat. Peptides 23, 1773-1781. (Pubitemid 35279836)
31. Boutrou R, Jardin J, Blais A, et al. (2008) Glycosylations ofkappa-casein-derived caseinomacropeptide reduce its accessibilityto endo-but not exointestinal brush border membranepeptidases. J Agric Food Chem 56, 8166-8173.
32. The Council of the European Communities (1986) CouncilDirective 86/609/EEC of 24 November 1986 on the approximationof laws, regulations and administrative provisions ofthe member states regarding the protection of animals usedfor experimental and scientific purposes. http://europa.eu.int/comm/ environment/chemicals/lab-animals/legislation-en.htm (accessed 25 April 2006).
33. Nowicki B, Holthöfer H, Saraneva T, et al. (1986) Location ofadhesion sites for P-fimbriated and for 075X-positive Escherichiacoli in the human kidney. Microb Pathog 1, 169-180. (Pubitemid 16000167)
34. Edelman S, Westerlund-Wikström B, Leskelä S, et al. (2002)In vitro adhesion specificity of indigenous lactobacilliwithin the avian intestinal tract. Appl Environ Microbiol 68,5155-5159. (Pubitemid 35154828)
35. Edelman S, Leskelä S, Ron E, et al. (2003) In vitro adhesionof an avian pathogenic Escherichia coli O78 strain to surfacesof the chicken intestinal tract and to ileal mucus. VetMicrobiol 91, 41-56. (Pubitemid 35346524)
36. Virkola R, Parkkinen J, Hacker J, et al. (1993) Sialyloligosaccharidechains of laminin as an extracellular matrix target forS fimbriae of Escherichia coli. Infect Immun 61, 4480-4484. (Pubitemid 23298613)
37. Joensuu JJ, Kotiaho M, Teeri TH, et al. (2006) GlycosylatedF4 (K88) fimbrial adhesion FaeG expressed in barleyendosperm induces ETEC-neutralizing antibodies in mice.Transgenic Res 15, 359-373. (Pubitemid 43901494)
38. Stumpe S & Bakker EP (1997) Requirement of a large K\+uptakecapacity and extracytoplasmic protease activity forprotamine resistance of Escherichia coli. Arch Microbiol167, 126-136. (Pubitemid 27141762)
39. Blanco M, Blanco J, Gonzalez E, et al. (1997) Genes codingfor enterotoxins and verotoxins in porcine Escherichia colistrains belonging to different O:K:H serotypes: relationshipwith toxic phenotypes. J Clin Microbiol 35, 2958-2963. (Pubitemid 27452443)
40. BSAS, British Society of Animal Science (2003) NutrientRequirement Standards for Pigs. Penicuik, Midlothian: BritishSociety of Animal Science.
41. Swidsinski A, Weber J, Loening-Baucke V, et al. (2005)Spatial organization and composition of the mucosal florain patients with inflammatory bowel disease. J Clin Microbiol43, 3380-3389. (Pubitemid 40981351)
42. AOAC (1995) Official Methods of Analysis. Arlington, VA:Association of Analytical Chemist.
43. Castillo M, Mart?́n-Orúe SM, Manzanilla EG, et al. (2006)Quantification of total bacteria, enterobacteria and lactobacillipopulations in pig digesta by real-time PCR. Vet Microbiol114, 165-170.
44. Setia A, Bhandari SK, House JD, et al. (2009) Developmentand in vitro evaluation of an Escherichia coli probioticable to inhibit the growth of pathogenic Escherichia coliK88. J Anim Sci 87, 2005-2012.
45. Jensen BB & Jorgensen H (1994) Effect of dietary fiber onmicrobial activity and microbial gas production in variousregions of the gastrointestinal tract of pigs. Appl EnvironMicrobiol 60, 1897-1904. (Pubitemid 24165835)
46. Nofrarias M, Manzanilla EG, Pujols J, et al. (2006) Effects ofspray-dried porcine plasma and plant extracts on intestinalmorphology and on leukocyte cell subsets of weaned pigs.J Anim Sci 84, 2735-2742. (Pubitemid 44505435)
47. SAS Inc. (1999) SASw User's Guide Statistics. Cary, NC: SASInc.
48. Melt H, Kloetzlen L & Vosbeck K (1983) Properties of pillifrom Escherichia coli SS142 that mediate mannose-resistantadhesion to mammalian cells. J Bacteriol 153, 1038-1044. (Pubitemid 13165044)
49. Arumugam RG, Hsieh CY, Tanzer ML, et al. (1986) Structuresof the asparagine-linked sugar chains of laminin. BiochimBiophys Acta 88, 112-126. (Pubitemid 16011410)
50. Anderson MJ, Whitehead JS & Kim YS (1980) Interaction ofEscherichia coli K88 antigen with porcine intestinal brushborder membranes. Infect Immun 29, 897-901. (Pubitemid 10009289)
51. Brück WM, Graverholt G & Gibson GR (2003) A two-stagecontinuous culture system to study the effect of supplementala-lactalbumin and glycomacropeptide on mixed culturesof human gut bacteria challenged with enteropathogenicEscherichia coli and Salmonella serotype Typhimurium. JAppl Microbiol 95, 44-53. (Pubitemid 36791865)
52. Strömqvist M, Falk P, Lennart Hansson SB, et al. (1995)Human milk k-casein and inhibition of Helicobacter pyloriadhesion to human gastric mucosa. J Pediatr GastroenterolNutr 21, 288-296.
53. Schroten H, Plogmann R, Hanisch F, et al. (1993) Inhibitionof adhesion of S-fimbriated Escherichia coli to buccalepithelial cells by human skim milk is predominantlymediated by mucins and depends on the period of lactation.Acta Paediatr 82, 6-11. (Pubitemid 23070580)
54. Mouricout M, Petit JM, Carias JR, et al. (1990) Glycoproteinglycans that inhibit adhesion of Escherichia coli mediatedby K99 fimbriae: treatment of experimental colibacillosis.Infect Immun 58, 98-106. (Pubitemid 20064870)
55. Blachier F, Mariotti F, Huneau JF, et al. (2007) Effects ofamino acid-derived luminal metabolites on the colonic epitheliumand physiopathological consequences. AminoAcids 33, 547-562. (Pubitemid 350165432)
56. Erickson RH & Kim YS (1990) Digestion and absorption ofdietary protein. Annu Rev Med 41, 133-139.
57. Piñeiro C, Piñeiro M, Morales J, et al. (2009) Pig-MAP andhaptoglobin concentration reference values in swine fromcommercial farms. Vet J 179, 78-84.
58. Scheppach W (1994) Effects of short chain fatty acids on gutmorphology and function. Gut 35, Suppl. 1 S35-S38. (Pubitemid 24059504)
59. Guilloteau P, Martin L, Eeckhaut V, et al. (2010) From the gutto the peripheral tissues: the multiple effects of butyrate.Nutr Res Rev 23, 366-384.
60. Janer C, Peláez C & Requena T (2004) Caseinomacropeptideand whey protein concentrate enhance Bifidobacteriumlactis growth in milk. Food Chem 86, 263-267. (Pubitemid 38292197)
61. Brück WM, Redgrave M, Tuohy KM, et al. (2006) Effects ofbovine alfa-lactalbumin and casein glycomacropeptideenichedinfant formulae on faecal microbiota in healthyterm infants. J Pediatr Gastroenterol Nutr 43, 673-679. (Pubitemid 44863697)
62. Nakajima K, Tamura N, Kobayashi-Hattori K, et al. (2005)Prevention of intestinal infection by glycomacropeptide.Biosci Biotechnol Biochem 69, 2294-2301. (Pubitemid 43004370)